CAMBRIDGE, Mass., Feb. 28, 2017 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the
field of cellular metabolism to treat cancer and rare genetic diseases, today announced the company is scheduled to present at the
Cowen and Company 37th Annual Health Care Conference in Boston on Monday, March 6, 2017 at 2:00 p.m. ET.
A live webcast of the presentation can be accessed under "Events & Presentations" in the Investors section of the company's
website at agios.com. A replay of the webcast will be archived on the Agios website for at least two weeks following the
presentation.
About Agios
Agios is focused on discovering and developing novel investigational medicines to treat cancer and rare genetic diseases through
scientific leadership in the field of cellular metabolism. In addition to an active research and discovery pipeline across both
therapeutic areas, Agios has multiple first-in-class investigational medicines in clinical and/or preclinical development. All
Agios programs focus on genetically identified patient populations, leveraging our knowledge of metabolism, biology and genomics.
For more information, please visit the company's website at www.agios.com.
Contacts Investors: Kendra Adams, 617-844-6407 Senior Director, Investor & Public Relations Kendra.Adams@agios.com Renee Leck, 617-649-8299 Senior Manager, Investor & Public Relations Renee.Leck@agios.com
